Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OSL/NYKD stock hub

OSL/NYKD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/NYKDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Oslo Børs

Market data

Live price

Current market quote for this ticker.

Current price

OSL/NYKD

In the news

Latest news · OSL/NYKD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-10.7

P25 n/aP50 n/aP75 n/a

ROIC-79.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/NYKD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	59
Employees Change	-77%
Employees Change Percent	-56.62
Enterprise value	NOK 464.5M
Exchange	Oslo Børs
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	NO0010714785
Last refreshed	2026-05-10
Market cap	NOK 1B
Price	NOK 3.21
Price currency	NOK
Rev Per Employee	77,399.2x
Sector	Healthcare
Sic	2836
Symbol	osl/NYKD
Website	https://nykode.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.79%
EV Earnings	-3.76x
EV/FCF	-1.56x
EV/Sales	101.72x
FCF yield	-28.41%
P/B ratio	1.13x
P/S ratio	229.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	NOK 4.6M
Gross Profit Growth	-95.05%
Gross Profit Growth3 Y	-63.12%
Gross Profit Growth5 Y	-70.86%
Net Income	NOK -123.4M
Net Income Growth Years	1%
Pretax Margin	-3,906.62%
Profit Per Employee	NOK -2.1M
ROA	-14.1
Roa5y	-12.81
ROCE	-30.49
ROE	-10.75
Roe5y	-17.36
ROIC	-79.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	89.22%
Cagr3y	-42.8%
Cagr5y	-42.47%
EPS Growth Years	1
Revenue Growth	-95.05x
Revenue Growth Years	0x
Revenue Growth3 Y	-63.12x
Revenue Growth5 Y	-70.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 0
Assets	NOK 1B
Cash	NOK 607.8M
Current Assets	NOK 570M
Current Liabilities	NOK 57M
Debt	NOK 25.7M
Debt Equity	NOK 0.03
Debt FCF	NOK -0.09
Equity	NOK 922.8M
Interest Coverage	-230.5
Liabilities	NOK 84.9M
Long Term Assets	NOK 437.6M
Long Term Liabilities	NOK 27.8M
Net Cash	NOK 582M
Net Cash By Market Cap	NOK 55.61
Net Cash Growth	-48.43%
Net Debt Equity	NOK -0.63
Tangible Book Value	NOK 922M
Tangible Book Value Per Share	NOK 2.82
WACC	8.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10
Net Working Capital	NOK -33.7M
Quick ratio	9.88
Working Capital	NOK 561.5M
Working Capital Turnover	NOK 0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth Years	1%
Dividend per share	NOK 1
Dividend Years	1
Dividend Yield	31.2%
Last Dividend	NOK 1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	89.14%
200-day SMA	2.46
3Y total return	-81.29%
50-day SMA	3.16
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.69%
All Time High	93
All Time High Change	-96.55%
All Time High Date	2021-02-16
All Time Low	1.44
All Time Low Change	122.57%
All Time Low Date	2025-09-11
ATR	0.19
Beta	0.86
Beta1y	-0.23
Beta2y	-0.01
Ch YTD	32.88
High	3.25
High52	4.1
High52 Date	2026-02-24
High52ch	-21.83%
Low	3.15
Low52	1.44
Low52 Date	2025-09-11
Low52ch	122.57%
Ma50ch	1.46%
Price vs 200-day SMA	30.13%
RSI	51.02
RSI Monthly	35.76
RSI Weekly	56.59
Sharpe ratio	1.18x
Sortino ratio	2.2
Total Return	31.2%
Tr YTD	32.88
Tr1m	-1.23%
Tr1w	1.59%
Tr3m	5.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -288.2M
Operating margin	-6,310.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	169,578,120%
Net Borrowing	-11,051,160
Shares Insiders	13.39%
Shares Institutions	32.16%
Shares Out	326,546,444
Shares Qo Q	9.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK -297M
Average Volume	852,255.5x
Bv Per Share	2.83
CAPEX	NOK -383,066
Ch1m	-1.23
Ch1w	1.59
Ch1y	23.55
Ch3m	5.99
Ch3y	-87.78
Ch5y	-95.88
Ch6m	22.14
Change	0%
Change From Open	0.47
Close	3.21
Days Gap	-0.47
Depreciation Amortization	6,741,207.6
Dollar Volume	869,625.5
Earnings Date	2026-04-17
EBIT	NOK -288.2M
EBITDA	NOK -280.8M
EPS	NOK -0.4
F Score	0
FCF	NOK -297.3M
FCF EV Yield	-64x
FCF Per Share	NOK -0.91
Financing CF	-338,670,861
Fiscal Year End	December
Founded	2,006
Income Tax	NOK -55M
Investing CF	35,443,706
Is Primary Listing	1
Last Earnings Date	2026-04-17
Last Report Date	2025-12-31
Last Split Date	2020-07-07
Last Split Type	Forward
Ma150	2.73
Ma150ch	17.36%
Ma20	3.21
Ma20ch	-0.28%
Net CF	-555,536,745
Next Earnings Date	2026-05-27
Open	3.19
Payment Date	2025-06-12
Position In Range	57.89
Ppne	52,345,661.2
Price Date	2026-05-08
Ptbv Ratio	1.14
Relative Volume	0.32x
Revenue	4,566,553x
SBC By Revenue	-6.62x
Share Based Comp	-302,421
Tax By Revenue	-1,204.64x
Tr6m	22.14%
Volume	271,334
Z Score	4.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

OSL/NYKD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+31.2%

$1.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+31.2%

Dividend yield + buyback yield combined

Performance

OSL/NYKD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OSL/NYKD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.2%

Share of float held by funds and institutions

Insider ownership

+13.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

OSL/NYKD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.0

Neutral momentum band

Price vs 200-day MA

+30.1%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

1.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/NYKD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/NYKD stock rating?

osl/NYKD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/NYKD analysis?

The full report lives at /stocks/osl/NYKD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/NYKD?

The latest report frames osl/NYKD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/NYKD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.